ESR1 and breast carcinoma: Gene set enrichment analyses have revealed that ligand-induced transactivation of the human epidermal growth factor receptor 2 (HER2) or other members of the EGFR family in HER2-negative tumors generates an overlapping gene signature to that of the highly proliferative luminal-B subtype of ER+ breast carcinomas [8].